GenBio AI is building foundation models for computational biology, with a tech stack emphasizing large-scale ML infrastructure (PyTorch, JAX, Kubeflow, GPU/CUDA) and web APIs (FastAPI, GraphQL, React). The hiring profile—8 research roles, 8 engineering roles, and 8 interns across three continents—reflects a startup in rapid scaling mode, balancing model development with production operationalization. Pain points around GPU resource scaling, R&D-to-production transitions, and academic partnership onboarding suggest they are moving beyond prototype toward reproducible, deployable systems.
GenBio AI develops integrated multiscale foundation models to simulate biology and predict disease mechanisms. Founded in 2024, the company is headquartered in Palo Alto and maintains offices in Paris and Abu Dhabi, drawing founding researchers from CMU, MBZUAI, and WIS. The core product surfaces include biology foundation models, a molecule design platform, and infrastructure for operationalizing those models into production workflows. The company is actively hiring across engineering, research, and data roles, with accelerating hiring velocity and a mix of interns, mid-level, and senior technical talent.
Python, PyTorch, JAX, TensorFlow, Kubeflow, Ray, and GPU/CUDA for ML workloads; FastAPI and GraphQL for APIs; React and TypeScript for frontend; Kubernetes and ArgoCD for orchestration; AWS, GCP, Azure, and OCI for cloud infrastructure.
Biology foundation models, molecule design platforms, large-scale experiments and hyperparameter searches, automated ML pipelines, and production infrastructure to operationalize foundation models for drug design and biomedical research.
Other companies in the same industry, closest in size